HK1138853A1 - Vaccine - Google Patents

Vaccine

Info

Publication number
HK1138853A1
HK1138853A1 HK10104329.2A HK10104329A HK1138853A1 HK 1138853 A1 HK1138853 A1 HK 1138853A1 HK 10104329 A HK10104329 A HK 10104329A HK 1138853 A1 HK1138853 A1 HK 1138853A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
Prior art date
Application number
HK10104329.2A
Other languages
English (en)
Inventor
Normand Blais
Denis Martin
Remi M Palmantier
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39300029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1138853(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0700760A external-priority patent/GB0700760D0/en
Priority claimed from GB0701262A external-priority patent/GB0701262D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of HK1138853A1 publication Critical patent/HK1138853A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001189—PRAME
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10104329.2A 2007-01-15 2010-05-03 Vaccine HK1138853A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0700760A GB0700760D0 (en) 2007-01-15 2007-01-15 Vaccine
GB0701262A GB0701262D0 (en) 2007-01-23 2007-01-23 Vaccine
PCT/EP2008/050290 WO2008087102A1 (en) 2007-01-15 2008-01-11 Vaccine

Publications (1)

Publication Number Publication Date
HK1138853A1 true HK1138853A1 (en) 2010-09-03

Family

ID=39300029

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104329.2A HK1138853A1 (en) 2007-01-15 2010-05-03 Vaccine

Country Status (32)

Country Link
US (1) US20080187535A1 (xx)
EP (1) EP2114993B1 (xx)
JP (1) JP5391080B2 (xx)
KR (1) KR20090101313A (xx)
CN (1) CN101668770B (xx)
AR (1) AR064862A1 (xx)
AU (1) AU2008207025B2 (xx)
BR (1) BRPI0806463A2 (xx)
CA (1) CA2674552A1 (xx)
CL (1) CL2008000104A1 (xx)
CO (1) CO6210757A2 (xx)
CR (1) CR10971A (xx)
CY (1) CY1113760T1 (xx)
DK (1) DK2114993T3 (xx)
DO (1) DOP2009000167A (xx)
EA (1) EA016326B1 (xx)
ES (1) ES2393812T3 (xx)
HK (1) HK1138853A1 (xx)
HR (1) HRP20120828T1 (xx)
IL (1) IL199663A0 (xx)
JO (1) JO2840B1 (xx)
MA (1) MA31093B1 (xx)
MX (1) MX2009007571A (xx)
MY (1) MY153679A (xx)
NZ (1) NZ578285A (xx)
PE (2) PE20130324A1 (xx)
PL (1) PL2114993T3 (xx)
PT (1) PT2114993E (xx)
SI (1) SI2114993T1 (xx)
TW (1) TWI434697B (xx)
WO (1) WO2008087102A1 (xx)
ZA (1) ZA200904923B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200902049A (en) * 2007-01-15 2009-01-16 Glaxosmithkline Biolog Sa Fusion protein
AU2010225125A1 (en) 2009-03-17 2011-10-20 Glaxosmithkline Biologicals S.A. Improved detection of gene expression
JP2012529269A (ja) * 2009-06-05 2012-11-22 ジ オハイオ ステイト ユニヴァーシティ リサーチ ファウンデーション 生体材料、組成物及び方法
GB0910046D0 (en) 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions
GB201008682D0 (en) * 2010-05-25 2010-07-07 Vib Vzw Epitope tag for affinity based applications
GB201101331D0 (en) * 2011-01-26 2011-03-09 Glaxosmithkline Biolog Sa Compositions and uses
KR20140049569A (ko) * 2011-07-22 2014-04-25 글락소스미스클라인 바이오로지칼즈 에스.에이. Ｐｒａｍｅ 정제
GB201114919D0 (en) * 2011-08-30 2011-10-12 Glaxosmithkline Biolog Sa Method
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
RU2590701C2 (ru) * 2013-04-29 2016-07-10 Общество с ограниченной ответственностью "ГеноТехнология" Антигенная композиция и ее терапевтическое применение для профилактики и лечения онкологических заболеваний, рекомбинантная плазмидная днк, обеспечивающая синтез гибридного белка, а также способ получения белка
EP3053592A4 (en) 2013-10-01 2017-09-06 Mie University T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
CN105254767A (zh) * 2015-11-17 2016-01-20 重庆科润生物医药研发有限公司 一种Protein D与HER2融合蛋白及其制备方法和应用
CN110506107A (zh) 2016-11-30 2019-11-26 阿德瓦希斯公司 靶向复发性癌症突变的免疫原性组合物及其使用方法
CN108264550B (zh) * 2017-01-04 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别源自于prame抗原短肽的tcr
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别prame抗原短肽的tcr及其相关组合物
WO2019061297A1 (zh) * 2017-09-29 2019-04-04 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN111655714A (zh) * 2017-11-08 2020-09-11 阿德瓦希斯公司 来自癌症相关蛋白的免疫原性异变肽及其使用方法
CN109879957B (zh) * 2017-12-06 2022-03-18 香雪生命科学技术（广东）有限公司 针对prame的高亲和力t细胞受体
US20230190902A1 (en) * 2020-05-29 2023-06-22 Children's National Medical Center Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame
TW202309071A (zh) 2021-05-05 2023-03-01 德商英麥提克生物技術股份有限公司 特異性結合ｐｒａｍｅ之抗原結合蛋白

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
CA2156718A1 (en) * 1993-12-23 1995-06-29 Bruno Gander Immunological response potentiation process
US5830753A (en) 1994-09-30 1998-11-03 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
HU228467B1 (en) 1998-02-05 2013-03-28 Smithkline Beecham Biolog Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
CA2363118A1 (en) * 1999-02-25 2000-08-31 Smithkline Beecham Biologicals S.A. Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
AU5821000A (en) * 1999-06-29 2001-01-31 Smithkline Beecham Biologicals (Sa) Vaccine
US6495347B1 (en) * 1999-07-08 2002-12-17 Stressgen Biotechnologies Corporation Induction of a Th1-like response in vitro

Also Published As

Publication number Publication date
JO2840B1 (en) 2014-09-15
WO2008087102A1 (en) 2008-07-24
MX2009007571A (es) 2009-07-22
BRPI0806463A2 (pt) 2011-09-06
ES2393812T3 (es) 2012-12-28
EA200900795A1 (ru) 2010-02-26
JP2010515444A (ja) 2010-05-13
EP2114993A1 (en) 2009-11-11
AU2008207025B2 (en) 2012-08-23
IL199663A0 (en) 2010-04-15
KR20090101313A (ko) 2009-09-24
PL2114993T3 (pl) 2013-01-31
CN101668770A (zh) 2010-03-10
HRP20120828T1 (hr) 2012-11-30
MA31093B1 (fr) 2010-01-04
CA2674552A1 (en) 2008-07-24
PE20130324A1 (es) 2013-03-05
US20080187535A1 (en) 2008-08-07
PT2114993E (pt) 2012-11-28
ZA200904923B (en) 2012-12-27
CN101668770B (zh) 2013-06-12
CR10971A (es) 2009-09-09
TWI434697B (zh) 2014-04-21
CY1113760T1 (el) 2016-07-27
MY153679A (en) 2015-03-13
DOP2009000167A (es) 2009-07-15
AR064862A1 (es) 2009-04-29
CL2008000104A1 (es) 2008-07-18
AU2008207025A1 (en) 2008-07-24
JP5391080B2 (ja) 2014-01-15
NZ578285A (en) 2011-12-22
EP2114993B1 (en) 2012-08-29
SI2114993T1 (sl) 2012-12-31
CO6210757A2 (es) 2010-10-20
EA016326B1 (ru) 2012-04-30
TW200902048A (en) 2009-01-16
DK2114993T3 (da) 2012-10-22
PE20081686A1 (es) 2008-12-25

Similar Documents

Publication Publication Date Title
HK1138853A1 (en) Vaccine
IL201782A0 (en) Vaccine
GB0717911D0 (en) Vaccine
HRP20151124T1 (xx) Cjepivo
ZA201004303B (en) Vaccine
GB0700135D0 (en) Vaccine
ZA201001029B (en) Vaccines
GB0711858D0 (en) Vaccine
GB0822001D0 (en) Vaccine
GB0810710D0 (en) Vaccine
GB0816284D0 (en) Vaccine
GB0816447D0 (en) Vaccine
GB0710538D0 (en) Vaccine
ZA201003851B (en) Vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0706825D0 (en) Vaccine
GB0721928D0 (en) Vaccine
GB0712062D0 (en) Vaccine
GB0712428D0 (en) Vaccine
GB0725121D0 (en) Vaccine
GB0708522D0 (en) Vaccine
GB0707697D0 (en) Vaccine
GB0725107D0 (en) Vaccine
GB0712658D0 (en) Vaccine
GB0712420D0 (en) Vaccine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170111